Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Raises $2.1M in Bridge Financing


OpGen has raised $2.1 million in a securities offering, the company disclosed in a filing with the US Securities and Exchange Commission last week.

The funding round, which had 27 participants, is a bridge financing that will be used to commercialize the Argus Optical Mapping System, the Gaithersburg, Md.-based company told In Sequence's sister publication GenomeWeb Daily News this week. According to the filing, the total size of the round is $2.3 million.

A couple of months ago, the company increased the amount of mapping data the Argus system can produce to 2.5 gigabases per day, making it more useful for the de novo assembly of large genomes. It is also working on a whole-chromosome de novo assembly application to screen for structural variations (IS 10/18/2011).

In a number of demonstration projects, the company has shown that its technology is useful to compare the genomes of different microbial strains, to assist and verify the assembly of microbes, and to help with the assemblies of human, plant, and animal genomes (IS 7/5/2011).

A year ago, OpGen raised $17 million in a Series B financing round, and added another $3 million as part of the same round earlier this year.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.